{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T04:37:50Z","timestamp":1776832670172,"version":"3.51.2"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T00:00:00Z","timestamp":1453852800000},"content-version":"vor","delay-in-days":725,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","pediatr-neonatol.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pediatrics & Neonatology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.pedneo.2013.05.009","type":"journal-article","created":{"date-parts":[[2013,8,3]],"date-time":"2013-08-03T09:15:14Z","timestamp":1375521314000},"page":"48-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Clinical Effectiveness of Aripiprazole in Short-term Treatment of Tic Disorder in Children and Adolescents: A Naturalistic Study"],"prefix":"10.1016","volume":"55","author":[{"given":"Che-Sheng","family":"Ho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan-Chang","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Fan","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-Ling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pedneo.2013.05.009_bib1","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.ncl.2009.04.011","article-title":"Tourette syndrome","volume":"27","author":"Jimenez-Shahed","year":"2009","journal-title":"Neurol Clin"},{"key":"10.1016\/j.pedneo.2013.05.009_bib2","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nurx.2006.01.009","article-title":"Contemporary assessment and pharmacotherapy of Tourette syndrome","volume":"3","author":"Scahill","year":"2006","journal-title":"NeuroRX"},{"key":"10.1016\/j.pedneo.2013.05.009_bib3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archpsyc.1973.01750310070010","article-title":"Treatment of Tourette's syndrome with haloperidol, review of 34 cases","volume":"28","author":"Shapiro","year":"1973","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"10.1016\/j.pedneo.2013.05.009_bib4","first-page":"CD006996","article-title":"Pimozide for tics in Tourette's syndrome","author":"Pringsheim","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pedneo.2013.05.009_bib5","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/archpsyc.1989.01810080052006","article-title":"Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome","volume":"46","author":"Shapiro","year":"1989","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pedneo.2013.05.009_bib6","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1345\/aph.1C297","article-title":"Aripiprazole: a new atypical antipsychotic drug","volume":"37","author":"Bowles","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.pedneo.2013.05.009_bib7","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0929-6646(09)60406-X","article-title":"Short-term sulpiride treatment of children and adolescents with Tourette syndrome or chronic tic disorder","volume":"108","author":"Ho","year":"2009","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.pedneo.2013.05.009_bib8","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1212\/01.WNL.0000055434.39968.67","article-title":"A placebo-controlled trial of risperidone in Tourette syndrome","volume":"60","author":"Scahill","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.pedneo.2013.05.009_bib9","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/cap.2007.135","article-title":"Effectiveness and tolerability of open label olanzapine in children and adolescents with Tourette syndrome","volume":"18","author":"McCracken","year":"2008","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.pedneo.2013.05.009_bib10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1176\/ajp.136.3.317","article-title":"The trial use of clozapine for abnormal involuntary movement disorders","volume":"136","author":"Caine","year":"1979","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pedneo.2013.05.009_bib11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1097\/00004583-200003000-00010","article-title":"Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study","volume":"39","author":"Sallee","year":"2000","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.pedneo.2013.05.009_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/104454603322572624","article-title":"Quetiapine treatment of children and adolescents with Tourette's disorder","volume":"13","author":"Mukaddes","year":"2003","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.pedneo.2013.05.009_bib13","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/00004583-200203000-00013","article-title":"Risperidone versus clonidine in the treatment of children and adolescents with Tourette's syndrome","volume":"41","author":"Gaffney","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.pedneo.2013.05.009_bib14","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1017\/S1461145705005365","article-title":"Case series on the use of aripiprazole for Tourette syndrome","volume":"8","author":"Murphy","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.pedneo.2013.05.009_bib15","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/hup.798","article-title":"A case series of patients with Tourette's syndrome in the United Kingdom treated with aripiprazole","volume":"21","author":"Davies","year":"2006","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.pedneo.2013.05.009_bib16","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.4088\/JCP.v68n0717","article-title":"An open-label study of the efficacy and tolerability of aripiprazole for children and adolescents with tic disorders","volume":"68","author":"Yoo","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pedneo.2013.05.009_bib17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/cap.2007.0064","article-title":"Aripiprazole treatment of children and adolescents with Tourette disorder or chronic tic disorder","volume":"18","author":"Seo","year":"2008","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.pedneo.2013.05.009_bib18","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1089\/cap.2009.0035","article-title":"Aripiprazole in children and adolescents with Tourette's disorder: an open-label safety and tolerability study","volume":"19","author":"Lyon","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.pedneo.2013.05.009_bib19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1089\/cap.2008.093","article-title":"Aripiprazole in pervasive developmental disorder not otherwise specified and Asperger's disorder: a 14-week, prospective, open-label study","volume":"19","author":"Stigler","year":"2009","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.pedneo.2013.05.009_bib20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10597-008-9154-7","article-title":"A non-randomized, open study with aripiprazole and ziprasidone for the treatment of aggressive behavior in youth in a community clinic","volume":"45","author":"Bastiaens","year":"2009","journal-title":"Community Ment Health J"},{"key":"10.1016\/j.pedneo.2013.05.009_bib21","first-page":"250","article-title":"Focus on aripiprazole: a review of its use in child and adolescent psychiatry","volume":"18","author":"Greenaway","year":"2009","journal-title":"J Can Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.pedneo.2013.05.009_bib22","doi-asserted-by":"crossref","first-page":"660","DOI":"10.2471\/BLT.07.043497","article-title":"Development of a WHO growth reference for school-aged children and adolescents","volume":"85","author":"de Onis","year":"2007","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.pedneo.2013.05.009_bib23","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1517\/14656566.3.5.479","article-title":"Psychotropic drugs and the ECG: focus on the QTc interval","volume":"3","author":"Goodnick","year":"2002","journal-title":"Expert Opin Pharmacother"}],"container-title":["Pediatrics & Neonatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957213001137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875957213001137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T01:25:45Z","timestamp":1539480345000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875957213001137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S1875957213001137"],"URL":"https:\/\/doi.org\/10.1016\/j.pedneo.2013.05.009","relation":{},"ISSN":["1875-9572"],"issn-type":[{"value":"1875-9572","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Effectiveness of Aripiprazole in Short-term Treatment of Tic Disorder in Children and Adolescents: A Naturalistic Study","name":"articletitle","label":"Article Title"},{"value":"Pediatrics & Neonatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pedneo.2013.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}